144 related articles for article (PubMed ID: 35043173)
1. Methazolamide Attenuates the Development of Diabetic Cardiomyopathy by Promoting β-Catenin Degradation in Type 1 Diabetic Mice.
Chen X; Li Y; Yuan X; Yuan W; Li C; Zeng Y; Lian Y; Qiu X; Qin Y; Zhang G; Liu X; Luo C; Luo JD; Hou N
Diabetes; 2022 Apr; 71(4):795-811. PubMed ID: 35043173
[TBL] [Abstract][Full Text] [Related]
2. Methazolamide is a new hepatic insulin sensitizer that lowers blood glucose in vivo.
Konstantopoulos N; Molero JC; McGee SL; Spolding B; Connor T; de Vries M; Wanyonyi S; Fahey R; Morrison S; Swinton C; Jones S; Cooper A; Garcia-Guerra L; Foletta VC; Krippner G; Andrikopoulos S; Walder KR
Diabetes; 2012 Aug; 61(8):2146-54. PubMed ID: 22586591
[TBL] [Abstract][Full Text] [Related]
3. Luteolin Attenuates Diabetic Myocardial Hypertrophy by Inhibiting Proteasome Activity.
Li XB; Rekep M; Tian JH; Wu Q; Chen M; Yang S; Zhang LX; Zhang GP; Qin Y; Yu XY; Xue Q; Liu YH
Pharmacology; 2023; 108(1):47-60. PubMed ID: 36423586
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of NF-κB and Wnt/β-catenin/GSK3β Signaling Pathways Ameliorates Cardiomyocyte Hypertrophy and Fibrosis in Streptozotocin (STZ)-induced Type 1 Diabetic Rats.
Liu JJ; Shentu LM; Ma N; Wang LY; Zhang GM; Sun Y; Wang Y; Li J; Mu YL
Curr Med Sci; 2020 Feb; 40(1):35-47. PubMed ID: 32166663
[TBL] [Abstract][Full Text] [Related]
5. USP28 Serves as a Key Suppressor of Mitochondrial Morphofunctional Defects and Cardiac Dysfunction in the Diabetic Heart.
Xie SY; Liu SQ; Zhang T; Shi WK; Xing Y; Fang WX; Zhang M; Chen MY; Xu SC; Fan MQ; Li LL; Zhang H; Zhao N; Zeng ZX; Chen S; Zeng XF; Deng W; Tang QZ
Circulation; 2024 Feb; 149(9):684-706. PubMed ID: 37994595
[TBL] [Abstract][Full Text] [Related]
6. Selective deletion of endothelial cell calpain in mice reduces diabetic cardiomyopathy by improving angiogenesis.
Teng X; Ji C; Zhong H; Zheng D; Ni R; Hill DJ; Xiong S; Fan GC; Greer PA; Shen Z; Peng T
Diabetologia; 2019 May; 62(5):860-872. PubMed ID: 30778623
[TBL] [Abstract][Full Text] [Related]
7. Activation of nuclear β-catenin/c-Myc axis promotes oxidative stress injury in streptozotocin-induced diabetic cardiomyopathy.
Liu P; Su J; Song X; Wang S
Biochem Biophys Res Commun; 2017 Dec; 493(4):1573-1580. PubMed ID: 28989026
[TBL] [Abstract][Full Text] [Related]
8. FOXO1 reduces STAT3 activation and causes impaired mitochondrial quality control in diabetic cardiomyopathy.
Zhou L; Su W; Wang Y; Zhang Y; Xia Z; Lei S
Diabetes Obes Metab; 2024 Feb; 26(2):732-744. PubMed ID: 37961034
[TBL] [Abstract][Full Text] [Related]
9. 1,25-Dihydroxyvitamin-D3 prevents the development of diabetic cardiomyopathy in type 1 diabetic rats by enhancing autophagy via inhibiting the β-catenin/TCF4/GSK-3β/mTOR pathway.
Wei H; Qu H; Wang H; Ji B; Ding Y; Liu D; Duan Y; Liang H; Peng C; Xiao X; Deng H
J Steroid Biochem Mol Biol; 2017 Apr; 168():71-90. PubMed ID: 28216152
[TBL] [Abstract][Full Text] [Related]
10. The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy.
Waldman M; Nudelman V; Shainberg A; Zemel R; Kornwoski R; Aravot D; Peterson SJ; Arad M; Hochhauser E
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100876
[TBL] [Abstract][Full Text] [Related]
11. Hyperglycemia-Driven Inhibition of AMP-Activated Protein Kinase α2 Induces Diabetic Cardiomyopathy by Promoting Mitochondria-Associated Endoplasmic Reticulum Membranes In Vivo.
Wu S; Lu Q; Ding Y; Wu Y; Qiu Y; Wang P; Mao X; Huang K; Xie Z; Zou MH
Circulation; 2019 Apr; 139(16):1913-1936. PubMed ID: 30646747
[TBL] [Abstract][Full Text] [Related]
12. Compound SJ-12 attenuates streptozocin-induced diabetic cardiomyopathy by stabilizing SERCA2a.
Lou S; Zhu W; Yu T; Zhang Q; Wang M; Jin L; Xiong Y; Xu J; Wang Q; Chen G; Liang G; Hu X; Luo W
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167140. PubMed ID: 38548092
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice.
Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X
Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195
[TBL] [Abstract][Full Text] [Related]
14. Enhanced phosphoinositide 3-kinase(p110α) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetes.
Ritchie RH; Love JE; Huynh K; Bernardo BC; Henstridge DC; Kiriazis H; Tham YK; Sapra G; Qin C; Cemerlang N; Boey EJ; Jandeleit-Dahm K; Du XJ; McMullen JR
Diabetologia; 2012 Dec; 55(12):3369-81. PubMed ID: 23001375
[TBL] [Abstract][Full Text] [Related]
15. Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy.
Arow M; Waldman M; Yadin D; Nudelman V; Shainberg A; Abraham NG; Freimark D; Kornowski R; Aravot D; Hochhauser E; Arad M
Cardiovasc Diabetol; 2020 Jan; 19(1):7. PubMed ID: 31924211
[TBL] [Abstract][Full Text] [Related]
16. Mst1 knockdown alleviates cardiac lipotoxicity and inhibits the development of diabetic cardiomyopathy in db/db mice.
Xiong Z; Li Y; Zhao Z; Zhang Y; Man W; Lin J; Dong Y; Liu L; Wang B; Wang H; Guo B; Li C; Li F; Wang H; Sun D
Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165806. PubMed ID: 32320827
[TBL] [Abstract][Full Text] [Related]
17. Ophiopogonin D alleviates diabetic myocardial injuries by regulating mitochondrial dynamics.
Li W; Ji L; Tian J; Tang W; Shan X; Zhao P; Chen H; Zhang C; Xu M; Lu R; Guo W
J Ethnopharmacol; 2021 May; 271():113853. PubMed ID: 33485986
[TBL] [Abstract][Full Text] [Related]
18. Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway.
Soetikno V; Sari FR; Sukumaran V; Lakshmanan AP; Mito S; Harima M; Thandavarayan RA; Suzuki K; Nagata M; Takagi R; Watanabe K
Eur J Pharm Sci; 2012 Oct; 47(3):604-14. PubMed ID: 22564708
[TBL] [Abstract][Full Text] [Related]
19. N-acetylcysteine attenuates myocardial dysfunction and postischemic injury by restoring caveolin-3/eNOS signaling in diabetic rats.
Su W; Zhang Y; Zhang Q; Xu J; Zhan L; Zhu Q; Lian Q; Liu H; Xia ZY; Xia Z; Lei S
Cardiovasc Diabetol; 2016 Oct; 15(1):146. PubMed ID: 27733157
[TBL] [Abstract][Full Text] [Related]
20. Peroxiredomin-4 ameliorates lipotoxicity-induced oxidative stress and apoptosis in diabetic cardiomyopathy.
Zhang B; Li X; Liu G; Zhang C; Zhang X; Shen Q; Sun G; Sun X
Biomed Pharmacother; 2021 Sep; 141():111780. PubMed ID: 34130124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
